Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Despite their benefits, there are a number of things to consider before taking weight loss drugs – including possible ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

By helping patients achieve meaningful weight loss, semaglutide addresses one of the root causes of fatty liver disease rather than just treating symptoms. Beyond the liver-specific improvements ...

The study targets adults in China with overweight or obesity accompanied metabolic dysfunction-associated fatty liver disease (MAFLD ... of mazdutide versus semaglutide in Chinese adults with ...

SAN FRANCISCO and SUZHOU, China, May 15, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that ...